Manufacturer record
Live Well Healthcare: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Live Well Healthcare (Himachal Pradesh) were declared Not of Standard Quality between July 2026 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
1 record linked to Live Well Healthcare in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Bupropion Hydrochloride Prolonged Release Tablets IP | LGT-260293Mfg 2026-02 · Exp 2028-01 | The sample does not conform to claim as per IP 2022 in respect to the Test of Identification by HPLC, Identification by IR and Assay of Bupropion Hydrochloride.Assay | RDTL, ChandigarhCDSCO lab | Jul 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.